The Heart Failure Congress is an ideal platform to learn about the latest Clinical Trial and Research or on-going trial.
Late Breaking Trials 1 on Sunday, 20 May - 14:45 - 15:45 in room Belgrade.
Chairpersons: S. D. Anker (Berlin, DE) - K. Swedberg (Goteborg, SE)
- Findings from SHIFT trial - Ivabradine improves clinical outcomes in patients with chronic systolic heart failure taking background treatment with aldosterone antagonists
- Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE)
- The C-CURE Multicenter Randomized Trial. - Cardiopoietic Stem Cell Transplantation in Heart FailURE.
- VitD - CHF Trial - An open-label, blinded-endpoint, randomized prospective trial investigating the effects of vitamin D administration on plasma renin activity in patients with stable chronic heart failure
- Eplerenone potassium and renal safety in the EMPHASIS-HF trial. Determinants and interactions with outcomes
- Baseline heart rate and heart rate reduction by ivabradine is more important than background dose of a beta-blocker - findings from SHIFT
- Hemodynamic and Echocardiographic Effects of Human Stresscopin in Patients with Heart Failure: A Randomized Multicenter Trial
See session in details here
Late Breaking Trials 2 on Monday, 21 May - 14:15 - 15:45 in room Belgrade.
Chairpersons: P. Ponikowski (Wroclaw, PL) - P. Seferovic (Belgrade, RS)
- Treatment of Functional Mitral Regurgitation by Percutaneous Annuloplasty: TITAN Trial
- A Double-Blind, Randomized, Parallel, Placebo Controlled Study Examining the Effect of Cross-linked Polyelectrolyte (CLP) in Heart Failure Patients with Chronic Kidney Disease - SORBENT CTST-21
- RAS-antagonists in HFPEF - Renin-angiotensin system antagonists are associated with reduced mortality in heart failure with preserved ejection fraction - a prospective propensity score-matched cohort study.
- LEAF - LEvosimendan in Acute heart Failure following acute myocardial infarction
- Prevalence of high resting heart rate in the contemporary population of patients with systolic heart failure in real life: the results from DATA-HELP
- IMPRES - Imatinib in Pulmonary arterial hypertension, a Randomized Efficacy Study
- Effect of digoxin in high-risk chronic heart failure patients: A pre-specified subgroup analysis of the Digitalis Investigation Group (DIG) trial
See session in details here
Ongoing Clinical Trial Forum:
Every year we provide a platform for organisers and sponsors of ongoing clinical trials in heart failure to advertise information about their trials to support finding new sites as well as to enhance patient recruitment and follow-up.
We invite you to come to the Clinical Trial Forum Area to find out more on
- The RESHAPE-HF Trial: A Randomized Study of the MitraClip Device in Heart Failure Patients with Clinically Significant Functional Mitral Regurgitation
- NECTAR-HF: Neurocardiac Therapy for Heart Failure
- ATOMIC-HF: Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure
These trials will be on display from Sunday until Tuesday and we ask the presenter to be available for discussion at each coffee break ..